JANE STREET GROUP, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$14,564,915
-12.3%
917,764
+4.3%
0.01%
-16.7%
Q2 2023$16,599,939
+25893.0%
879,700
+5189.5%
0.01%
Q1 2023$63,863
-81.3%
16,631
-75.9%
0.00%
Q4 2022$341,679
+155.0%
68,887
+145.9%
0.00%
Q3 2022$134,000
-16.8%
28,014
-21.5%
0.00%
Q2 2022$161,000
-88.5%
35,683
-87.9%
0.00%
Q1 2022$1,398,000
-59.0%
293,783
-36.1%
0.00%
-100.0%
Q4 2021$3,410,000
+122.1%
459,428
+69.7%
0.00%
Q3 2021$1,535,000
+57.4%
270,687
+83.0%
0.00%
Q2 2021$975,000
+6.3%
147,933
+30.6%
0.00%
Q1 2021$917,000
-5.7%
113,277
-24.7%
0.00%
Q4 2020$972,000
+148.0%
150,478
+38.1%
0.00%
Q3 2020$392,000
+45.2%
108,931
+85.6%
0.00%
Q2 2020$270,000
+718.2%
58,706
+333.2%
0.00%
Q3 2019$33,000
-93.5%
13,551
-94.2%
0.00%
-100.0%
Q2 2019$511,000
+50.3%
235,590
+233.1%
0.00%0.0%
Q4 2018$340,000
+178.7%
70,731
+449.8%
0.00%
Q3 2018$122,000
-79.4%
12,866
-78.8%
0.00%
-100.0%
Q2 2018$591,000
+88.8%
60,794
+104.3%
0.00%0.0%
Q1 2018$313,000
+389.1%
29,763
+197.6%
0.00%
Q4 2017$64,000
-89.7%
10,000
-87.7%
0.00%
-100.0%
Q3 2017$620,000
+566.7%
81,099
+518.9%
0.00%
Q2 2017$93,000
+86.0%
13,104
-46.8%
0.00%
Q4 2016$50,000
+28.2%
24,621
+67.3%
0.00%
Q3 2016$39,000
-71.9%
14,718
-5.1%
0.00%
-100.0%
Q1 2015$139,000
-46.3%
15,512
-36.6%
0.00%
-66.7%
Q3 2014$259,00024,4790.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders